Overview Fundamentals API Earnings EOD API Sample Code Pricing

Aclaris Therapeutics Inc (ACRS NASDAQ) stock market data APIs

$1.43 0.11(8.3%) as of July 17, 2024
Price chart is built with Anychart

Aclaris Therapeutics, Inc. a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. The company operates through two segments, Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment provides laboratory services. It develops Zunsemetinib (ATI-450), an MK2 inhibitor which is under Phase 1b/2 trials for the treatment of metastatic breast and pancreatic cancer; ATI-1777, a soft JAK 1/3 inhibitor, completed Phase 2b trails for the treatment of moderate to severe atopic dermatitis and other dermatologic conditions; and ATI-2138, an oral covalent inhibitor of ITK and JAK3 inhibitor under Phase 1 trials as a treatment for T cell-mediated autoimmune diseases. The company was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.

Aclaris Therapeutics Inc Financial Data Overview

98 702 K
71 265 K
31 119 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ACRS',
Type: 'Common Stock',
Name: 'Aclaris Therapeutics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG003LF0QR9',
CIK: '1557746',
EmployerIdNumber: '46-0571712',
FiscalYearEnd: 'December',
IPODate: '2015-10-07',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Diagnostics & Research',
HomeCategory: 'Domestic',
IsDelisted: false,

Aclaris Therapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 31 119 K
  • EBITDA -117 565 000
  • Earnings Per Share -1.09
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Aclaris Therapeutics Inc Earnings via APIs

  • Latest Release 2024-05-07
  • EPS/Forecast -0.29

Get Aclaris Therapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?